Test Price
2,800 AED✅ Home Collection Available
FBXL4 Gene Mitochondrial DNA Depletion Syndrome Type 13 Genetic Test in UAE | AED 2800 | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance
Telephonic Post-Test Guidance by certified specialists to interpret results in the UAE clinical context.
Insurance & Billing
Direct Billing Verification via WhatsApp: +971 54 548 8731
Test Overview & Methodology
The FBXL4 gene NGS test uses next-generation sequencing to identify pathogenic variants responsible for mitochondrial DNA depletion syndrome type 13, a severe neurometabolic disorder. This test provides single-gene resolution with deep coverage validated specifically for FBXL4, enabling precise molecular diagnosis and informed clinical management.
| Parameter | Our Test (FBXL4 NGS) | Closest Alternative (Whole Exome) |
|---|---|---|
| Precision | Single‑gene resolution with deep coverage; validated for FBXL4 | Broad exome coverage; may miss deep intronic variants |
| Method | Next‑Generation Sequencing (Illumina®) + bioinformatic confirmation | Whole Exome Sequencing |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Cost | AED 2800 | AED 4500+ |
Physician Insight & Safety Protocols
“This targeted FBXL4 genetic analysis provides high-confidence diagnostic evidence for mitochondrial DNA depletion syndrome type 13. However, results must be integrated with thorough clinical evaluation, neuroimaging, and metabolic profiling. A negative finding does not exclude all mitochondrial disorders; therefore, ongoing clinical surveillance and genetic counseling are strongly recommended.”
— Lina Osama Zaki Quteineh (DHA License: 9294403), Consultant Medical Genetics
Advisory Notice: Medication Continuity
⚠️ Critical Advisory: Do not discontinue prescribed medication without consulting your doctor. Genetic test results may inform therapy decisions but must never prompt abrupt drug cessation without direct physician guidance.
Exclusion Criteria & Emergency Indicators
Test Exclusion Criteria
- Minors under 16 years without parental/legal guardian consent and genetic counseling as per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Acute neurological decompensation (refer to emergency care first).
- Asymptomatic individuals seeking health screening without clinical indication or family history.
Emergency Red Flags (Urgent Hospital Visit)
- Sudden loss of consciousness or seizures.
- Respiratory insufficiency or apneic episodes.
- Severe metabolic acidosis or hypoglycemia.
- Rapid neurological regression with bulbar dysfunction.
Patient FAQ & Clinical Guidance
1. What is the FBXL4 gene test used for?
The FBXL4 gene test is used to diagnose mitochondrial DNA depletion syndrome type 13, a severe childhood‑onset neurological disorder causing developmental regression and brain dysfunction. This condition typically presents in infancy with hypotonia, feeding difficulties, and progressive encephalomyopathy. Identifying a biallelic pathogenic variant confirms the diagnosis, enables accurate genetic counseling, and guides disease‑specific surveillance.
2. When will my FBXL4 gene test results be ready?
FBXL4 gene test results are typically delivered within 3 to 4 weeks due to the intricate next‑generation sequencing and bioinformatic interpretation process. The laboratory first extracts DNA, enriches the FBXL4 gene, performs sequencing at high depth, and then expert geneticists interpret the variants. In urgent clinical situations, preliminary verbal reports can sometimes be expedited through direct contact with the consultant.
3. Can I request the FBXL4 test without a prescription in the UAE?
No, an FBXL4 genetic test legally requires a referral from a licensed neurologist or clinical geneticist after genetic counseling, in compliance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability. This regulation mandates pre‑counseling to explain the implications of mitochondrial DNA depletion findings. Our service verifies the referring physician credentials and confirms insurance pre‑approval before collection.
UAE Regulatory & Data Privacy Adherence
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed locally in UAE facilities with ISO 9001:2015 certification (INT/EGQ/2509DA/3139). Clinical testing safety and patient consent adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your data remains confidential and is used solely for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | FBXL4 Gene Mitochondrial DNA Depletion Syndrome Type 13 Genetic Test |
| Price (AED) | AED 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Next-Generation Sequencing (Illumina®) with Bioinformatic Confirmation |
| ICD-10-CM Code | E88.49 (Other mitochondrial metabolism disorders) |
| LOINC Code | 85725-9 (FBXL4 gene mutation analysis in blood) |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians